SCHEMBL31720945

SCHEMBL31720945

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ PDCD1LG2 Q9BQ51 1/20 0.48
▸ CD274 Q9NZQ7 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ ENPEP Q07075 9/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CA2 P00918 2/20 0.39
▸ CA1 P00915 1/20 0.39
▸ FPR2 P25090 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30807934 0.99 PDCD1LG2 (0.47) PDCD1LG2CD274ALDH1A1ENPEPL3MBTL1
SCHEMBL30807942 0.99 PDCD1LG2 (0.47) PDCD1LG2CD274ALDH1A1ENPEPL3MBTL1
SCHEMBL29697059 0.94 PDCD1LG2 (0.51) PDCD1LG2CD274ALDH1A1ENPEP
SCHEMBL3783791 0.92 ALDH1A1 (0.54) PDCD1LG2CD274ALDH1A1ENPEPL3MBTL1
SCHEMBL3783793 0.92 ALDH1A1 (0.54) PDCD1LG2CD274ALDH1A1ENPEPL3MBTL1
SCHEMBL29350950 0.87 ALDH1A1 (0.46) ALDH1A1ENPEPL3MBTL1CA2CA1
SCHEMBL30272531 0.87 ALDH1A1 (0.45) PDCD1LG2CD274ALDH1A1ENPEP
SCHEMBL31174311 0.86 CD274 (0.59) PDCD1LG2CD274ENPEPCA2CA1
SCHEMBL29572136 0.86 CD274 (0.59) PDCD1LG2CD274ENPEPCA2CA1
SCHEMBL29379448 0.86 CD274 (0.59) PDCD1LG2CD274ENPEPCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339504-A1 CANCER VACCINE WITH USE OF COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING RISK OF CANCER ONSET BY DETECTING CIRCULATING TUMOR CELLS NATIONAL CANCER CENTER (JP) 2025-11-06 — — US disclosed
Send feedback